Browse life science companies in Cambridge, home to one of Europe's leading biotechnology and life science ecosystems.
Phenotypic screening platform for targeted protein degradation drug discovery
PhoreMost is a drug discovery company developing a phenotypic screening platform to identify and prosecute previously undruggable disease targets. The platform systematically…
Next-generation sequencing and genomic analysis services
Novogene (UK) is a genomic services provider operating as the European hub of Novogene Corporation, one of the world's largest sequencing organisations. Based at Cambridge Science…
Microfluidic nanoparticle formulation instruments for gene and cell therapy
Unchained Labs (Royston) is a developer of microfluidic mixing instruments for nanoparticle and lipid nanoparticle formulation, spanning early-stage screening through GMP-ready…
End-to-end production systems for cultivated meat
Cellcraft is a biotechnology company developing integrated systems for cultivated meat production. The company supplies the hardware, software, and biological inputs required to…
AI-ready cellular perturbation datasets for drug discovery
CellCodex is a Cambridge-based company generating large-scale cellular perturbation datasets for the training of foundation AI models in biology. The company combines CRISPR…
Targeted oncology combination therapies in biomarker-defined cancer populations
Mosaic Therapeutics is a Cambridge biotech developing targeted combination therapies for cancer. Its proprietary platform integrates genome-scale CRISPR screening, high-throughput…
AAV gene therapy targeting the seizure focus in refractory epilepsy
EpilepsyGTx is a biotechnology company developing gene therapies for focal refractory epilepsy, a condition in which seizures arise from a specific brain region and do not respond…
Anti-inflammatory drugs for neurodegenerative disease
Sitala Bio is a Cambridge-based biotech developing small molecule drugs that target chronic neuroinflammation in conditions such as Parkinson's and Alzheimer's disease. The…
Whole genome synthesis platform engineering novel therapeutic biomolecules
Constructive Bio is a Cambridge-based synthetic biology company developing programmable biology platforms for the creation of novel biomolecules. Spun out of the MRC Laboratory of…
Automated benchtop instrumentation for rapid protein and viral vector quantification
Abselion develops automated analytical instrumentation for biomolecule quantification in biopharmaceutical research and manufacturing. Its technology enables rapid quantification…
AI-native platform for cell culture process design and optimisation
Tolemy Bio Ltd is a company developing an AI-native platform for cell therapy process development and manufacturing optimisation. The platform ingests experimental and bioreactor…
Clinical genomic decision support software for rare disease and oncology
Congenica is a clinical genomic interpretation platform spun out of the Wellcome Sanger Institute. Its software supports variant analysis and clinical reporting across rare…